ClinicalTrials.gov
public full text
Public Domain
Alternate Day Buprenorphine Administration, Phase IX - 14
The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Alternate-Day Buprenorphine Administration. Phase II - 4#839120
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4#891375
- Alternate Day Buprenorphine Administration, Phase XI - 16#969323
- Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance#900823
- Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers#885751
Record · ID 1173846
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive